In Vivo modulation of angiogenic gene expression by acycl nucleoside phosphonates PMEDAP and PMEG

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1295-1302

  Otová, Berta ^a   Hrdý, Jiří ^a   Votruba, Ivan ^b   Holý, Antonín ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

PMEDAP; PMEG; Proangiogenic genes; T cell sd lymphoma

Indexed keywords

9 [2 (PHOSPHONOMETHOXY)ETHYL] 2,6 DIAMINOPURINE; 9 [2 (PHOSPHONOMETHOXY)ETHYL]GUANINE; ACYCLIC NUCLEOSIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T CELL LYMPHOMA;

ADENINE; ANIMALS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE; LYMPHOMA, T-CELL; MALE; NEOVASCULARIZATION, PATHOLOGIC; ORGANOPHOSPHORUS COMPOUNDS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 64949121781     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Otová B, Sladká M, Damoiseaux J, Panczak A, Mandys V, Francová K and Kudláčková M: Characterization of T-cell lymphomas in the Prague inbred Sprague-Dawley/Cub rat strain-a model of spontaneous hematological malignancy. Transplant Proc 31 1618-1619,1999.
2. Otová B, Sladká M, Damoiseaux J, Panczak A, Mandys V and Marinov I: Relevant animal model of human lymphoblastic leukaemia/lymphoma - spontaneous T-cell lymphomas in an inbred Sprague-Dawley rat strain (SD/Cub). Folia Biol (Praha) 48: 213-226, 2002.
3. Otová B, Zídek Z, Holý A, Votruba I, Sladká M, Marinov I and Lešková V: Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP. In Vivo 11: 163-168, 1997.
4. Otová B, Francová K, Franěk F, Koutník P, Votruba I, Holý A, Sladká M and Schramlová J: 9-[2-(Phosphonomethoxy)ethyl]- 2,6-diaminopurine (PMEDAP) - a potential drug against hematological malignancies - induces apoptosis. Anticancer Res 19: 3173-3182, 1999.
5. Bobková K, Otová B, Marinov I Mandys V, Panczak A, Votruba I and Holý A: Anticancer effect of PMEDAP - monitoring of apoptosis. Anticancer Res 20: 1041-1048, 2000.
6. 6-substituted PMEDAP derivatives against T-cell lymphoma. Anticancer Res 21: 2057-2064, 2001.
7. 6- substituted derivatives: genotoxic effect and apoptosis in in vitro conditions. Anticancer Res 23: 4933-4939, 2003.
8. 6-substituted purine acyclic nucleoside phosphonates. Biochem Pharmacol 71: 1370-1376, 2006.
9. 6- substituted purine acyclic nucleoside phosphonates. Collect Czech Chem Commun 73: 275-291, 2008.
10. Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GHI, Deasai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R and Tumas DB: GS-9219 - A novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma. Clin Cancer Res 14: 2824-2832, 2008.
11. Krejčová R, Horská K, Votruba I and Holý A: Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes. Biochem Pharmacol 60: 1907-1913, 2000.
12. Horská K, Votruba I and Holý A: Interaction of phosphates of the acyclic nucleoside phosphonates with NDP kinase from yeast and bovine liver. Collect Czech Chem Commun 71: 35-43,2006.
13. Kramata P, Votruba I, Otová B and Holý A: Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases a, δ and ε. Mol Pharmacol 49: 1005 1011,1996.
14. Kramata P, Downey KM and Paborsky LR: Incorporation and excision of 9-(2-phosphonylmethoethyl)guanine (PMEG) by DNA polymerase δ and ε in vitro. J Biol Chem 275: 21966-21971,1998.
15. Hájek M, Matulová N, Votruba I, Holý A and Tloušt'ová E: Inhibition of human telomerase by diphosphates of acyclic nucleoside phosphonates. Biochem Pharmacol 70: 894-900, 2005.
16. Eskens F: Minireview: Angiogenesis inhibitors in clinical development: where are we now and where are we going? Brit J Cane 90: 1-7,2004
17. Soufla G, Sifakis S, Baritaki S, Zafiropulos A, Koumantakis E and Spandidos DA: VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett 18: 105-118, 2005.
18. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
19. Dong X, Han ZC and Yang R: Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit Rev Oncol Hematol 62: 105-118,2007.
20. Holý A, Rosenberg I and Dvořáková H: Synthesis of N-(2- phosphonylmethoxyethyl) derivatives of heterocyclic bases. Collect Czech Chem Commun 54: 2190-2210, 1990.
21. Terman BI and Stoletov K: VEGF and tumor angiogenesis. J Biol and Med 18: 59-66, 2001.
22. Shibuya M and Claesson-Welsh L: Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Res 312: 549-560, 2006,
23. Neri D and Bicknell R: Review; Tumor vascular targeting. Nature 5: 436-446, 2005.
24. Wróbel T, Poreba M, Mazur G, Poreba R, Pyszel A, Beck B, Steinmetz-Beck A, Andrzejak R and Kuliczkowski K: Angiogenic and coagulation-fibrinolysis factors in non Hodkin's lymphoma. Neoplasma 53: 253-258, 2006.
25. Dunn IF, Heese O and Black PM: Growth factors in glioma angiogenesis: FGFs, PDGF, EGF and TGFs. JNO 50: 121-137, 2000.
26. Harari PM: Review; Epidermal growth factor receptor inhibition strategies in oncology. Edocrine-Related Cane 11: 689-708,2004.
27. Jain RK and Booth MF: What brings pericytes to tumor vessels? J Clin Invest 112: 1134-1136, 2003
28. Vincent L and Rafii S:Vascular frontiers without borders: Multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis. Cancer Cell 6: 307-309, 2004.
29. Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GHI, Desai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R and Tumas DB: GS-9219 - a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-hodgkin's lymphoma. Clin Cancer Res 14: 2824-2832, 2008.